Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...
A decades-old way to bridge buyers and sellers on price, contingent value rights have recently seen an uptick in use due to a ...
Janux’s “masked” T cell engager had a lower response rate than reported last year. Elsewhere, Lilly dropped Zepbound’s price ...
The draft guidance issued Tuesday comes as regulators and policymakers have looked for ways to aid U.S. drugmakers amid fast progress by their China-based counterparts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback